Related Experiment Video

Updated: Aug 8, 2026

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
09:03

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

Published on: February 3, 2012

Platelet-associated IgM elevated in patients with chronic hepatitis C contains no anti-platelet autoantibodies

S Kosugi1, Y Imai, Y Kurata

  • 1The Second Department of Internal Medicine, Osaka University Medical School, Japan.

Liver
|December 5, 1997
PubMed

Insights

Thrombocytopenia in chronic hepatitis C patients is not caused by anti-platelet autoantibodies. While platelet-associated IgM (PAIgM) was elevated, it did not react with platelets, indicating a different underlying mechanism.

Area of Science:

  • Immunology
  • Hepatology
  • Hematology

Background:

  • Chronic hepatitis C virus (HCV) infection is often associated with thrombocytopenia.
  • The exact cause of thrombocytopenia in HCV patients remains unclear, with autoantibodies being a potential factor.

Purpose of the Study:

  • To investigate the role of anti-platelet autoantibodies in thrombocytopenia among patients with chronic hepatitis C.
  • To determine if elevated platelet-associated immunoglobulins (PAIg) in HCV patients correlate with reduced platelet counts.

Main Methods:

  • Direct immunofluorescent flow cytometry was used to measure platelet-associated IgG (PAIgG) and platelet-associated IgM (PAIgM).
  • PAIg levels were assessed in chronic hepatitis C patients, with comparisons made to patients with chronic immune thrombocytopenic purpura (ITP).
  • Eluted PAIgM was tested for reactivity with normal platelets, and PAIgM levels were monitored during alpha-interferon therapy.

Main Results:

  • Elevated PAIgM was found in 70% of chronic hepatitis C patients, and elevated PAIgG in 32%.
  • Elevated PAIgM was observed in both thrombocytopenic and non-thrombocytopenic HCV patients, with no correlation to platelet count.
  • Eluted PAIgM did not react with normal platelets, and PAIgM levels increased with decreasing platelet counts during alpha-interferon therapy.

Conclusions:

  • Elevated PAIgM in chronic hepatitis C patients does not indicate the presence of detectable anti-platelet autoantibodies.
  • Thrombocytopenia in chronic hepatitis C is not caused by anti-platelet autoantibodies.
  • The mechanism underlying thrombocytopenia in chronic hepatitis C requires further investigation beyond autoantibody involvement.

More Related Videos

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms11:36

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms

Published on: May 29, 2020

A Uniform Shear Assay for Human Platelet and Cell Surface Receptors via Cone-plate Viscometry04:32

A Uniform Shear Assay for Human Platelet and Cell Surface Receptors via Cone-plate Viscometry

Published on: June 5, 2019

Related Concept Videos

Transcytosis of IgG01:15

Transcytosis of IgG

Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Chronic Pancreatitis I: Introduction01:25

Chronic Pancreatitis I: Introduction

Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80% of...